TMCnet News

Sapiens Reports 16.3% Year-Over-Year Increase in Annual Revenue to $157.5 Million
[February 25, 2015]

Sapiens Reports 16.3% Year-Over-Year Increase in Annual Revenue to $157.5 Million


HOLON, Israel, Feb. 25, 2015 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector, and a member of the Formula Group (NASDAQ: FORTY), today announced record financial results for the fourth quarter and year ended December 31, 2014.

Sapiens International Corporation Logo

Fourth Quarter Highlights:

  • Non-GAAP revenue of $41.8 million, up 15.4% compared to $36.2 million in the fourth quarter of 2013.
  • Non-GAAP operating profit was $5.0 million, or 11.9% operating margin, compared to $3.8 million, or 10.4% operating margin, in the fourth quarter of 2013. The increase in operating profit was 31.9% and the Company's operating margin increased sequentially in each quarter of 2014.
  • Non-GAAP net income attributable to Sapiens' shareholders totaled $4.9 million or $0.10 per diluted share compared to $3.4 million, or $0.07 per diluted share in the fourth quarter last year.
  • Cash, cash equivalents and securities investments as of December 31, 2014 was $80.5 million, with no debt.

Full-Year Highlights:

  • Non-GAAP revenue increased by 16.3% to $157.5 million from $135.4 million in 2013.
  • Non-GAAP operating profit was $17.0 million compared to $14.0 million in 2013, an increase of 21.1%.
  • Non-GAAP net income attributable to Sapiens' shareholders reached $16.0 million, compared to $14.0 million in 2013, an increase of 14.2%.

Roni Al-Dor, President and CEO of Sapiens, commented: "We concluded 2014 with a solid revenue increase driven by growth in all of our products and in all of our geographic regions. With new versions released across our entire product line, an expanded sales team increasingly focused on global growth areas, and a stronghold position in the market, we are well positioned to continue our growth trajectory into 2015 and beyond. Our recent efforts to enhance our sales and marketing organization are paying off as we strengthen our brand recognition and increase our presence in the insurance industry. At the same time, the investments we have made in new product development are proving to be just what both our existing and prospective customers are looking for. I remain optimistic about both the near-term and long-term prospects for our market and the impact Sapiens will have as an innovative provider of software solutions."

"I am equally pleased with the improvement in our operating margins, as we completed the majority of the investments and demonstrated solid, sequential improvements in our operating margin during each quarter of the year," continued Mr. Al-Dor. "We expect continued improvement in our profitability in 2015 as we efficiently scale our business."

2015 Business Outlook

Management indicated it expects 2015 revenues to grow approximately 17% on a constant currency basis. Based on current exchange rates, and accounting for the foreign currency exchange rate impact, this represents full year 2015 revenue of approximately $174 to $178 million.

The company also expects full-year 2015 Non-GAAP operating margins in the range of 12% - 13%.

Quarterly Results Conference Call

Sapiens management will host its earnings conference call today, February 25 at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens' results. Please call the following numbers (at least 10 minutes before the scheduled time) to participate:

  • North America (toll-free): + 1-888-668-9141
  • International: +972-3-918-0609
  • UK: 0-800-917-5108

The live webcast of the call can be viewed on Sapiens' website at: http://www.sapiens.com/investors/presentations-and-webcast/

If you are unable to join live, a replay of the call will be accessible until March 4, 2015, as follows

  • North America: 1-888-782-4291
  • International: +972-3-925-5904

A recorded version of the webcast will also be available via the Sapiens website, for three months at the same location.

Non-GAAP Financial Measures

This press release contains the following non-GAAP financial measures: Non-GAAP revenue, Non-GAAP gross profit, Non-GAAP operating income, Non-GAAP net income attributed to Sapiens shareholders, Non-GAAP basic and diluted earnings per share.

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

Management of the Company does not consider these non-GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures. In order to compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

The Company defines Adjusted EBITDA as net Profit, adjusted for stock-based compensation expense, depreciation and amortization, capitalized internal-use software development costs, Amortization of internal-use software development costs interest expense, provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business. The Company uses Adjusted EBITDA as a measurement of its operating performance because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflect an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures provide a more complete understanding of factors and trends affecting its business.

About Sapiens

Sapiens International Corporation (NASDAQ and TASE: SPNS) is a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector. We offer core, end-to-end solutions to the global general insurance, property and casualty, life, pension and annuities, and retirement markets, as well as business decision management software. We have a track record of over 30 years in delivering superior software solutions to more than 130 financial services organizations. Our team of about 1,000 professionals operates through our fully-owned subsidiaries in North America, the United Kingdom, EMEA and Asia Pacific. For more information: www.sapiens.com.

Forward Looking Statement

Some of the statements in this press release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will," "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management's current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement. These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties as well as certain additional risks that we face, you should refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2013 and subsequent reports and registration statements filed from time to time with the Securities and Exchange Commission.

Investors and Media Contact:

Yaffa Cohen-Ifrah
Chief Marketing Officer and Head of Corporate Communications
Sapiens International
US Mobile: +1 201-250-9414
Mobile: +972 54-9099039
Email: [email protected]

 





 

Summary of Non-GAAP financial Information

U.S. dollars in thousands (except per share amounts)

 



 Three months ended


 Year ended



 December 31,


 December 31,



2014


2013


2014


2013



(unaudited)


(unaudited)


(unaudited)


(unaudited)










 Revenues


41,773


36,192


157,450


135,377

 Gross profit


17,478


14,854


64,193


55,790

   Gross Margin


41.8%


41.0%


40.8%


41.2%

 Operating profit


4,958


3,758


17,014


14,049

   Operating Margin


11.9%


10.4%


10.8%


10.4%

 Net income attributable to Sapiens' shareholders 


4,948


3,386


16,008


14,022

 Adjusted EBITDA


5,363


4,230


18,596


15,311

   EBITDA Margin


12.8%


11.7%


11.8%


11.3%

 Basic earnings per share


0.10


0.08


0.34


0.35

 Diluted earnings per share


0.10


0.07


0.33


0.33


 

 

Adjusted EBITDA Calculation

U.S. dollars in thousands

 



 Three months ended


 Year ended



 December 31,


 December 31,



2014


2013


2014


2013










GAAP operating profit


4,550


3,325


14,906


11,883










Non GAAP adjustments:









Amortization of capitalized software


1,194


1,130


4,926


4,500

Amortization of other intangible assets


544


525


2,209


2,125

Capitalization of software development


(1,556)


(1,456)


(6,094)


(5,392)

Stock-based compensation


226


234


1,067


933










Non GAAP operating profit


4,958


3,758


17,014


14,049










Depreciation


405


472


1,582


1,262










Adjusted EBITDA


5,363


4,230


18,596


15,311

 

 

Revenues by category

U.S. dollars in thousands

 


Three months ended
December 31, 2014


Year ended
December 31, 2014


Revenues

Percentage


Revenues

Percentage



License

2,439

5.8%


13,204

8.4%

Services and Maintenance

39,334

94.2%


144,246

91.6%

Total

41,773

100.0%


157,450

100.0%

 

 

Revenues by geographic breakdown

U.S. dollars in thousands

 


Three months ended

December 31, 2014


Year ended

 December 31, 2014


Revenues

Percentage


Revenues

Percentage



North America

13,560

32.5%


49,585

31.5%

Europe

23,119

55.3%


92,133

58.5%

APAC

5,094

12.2%


15,732

10%

Total

41,773

100%


157,450

100%

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

U.S. dollars in thousands (except per share amounts)

 




  Three months ended


  Year ended




 December 31,


 December 31,




2014


2013


2014


2013




 (unaudited)


 (unaudited)


 (unaudited)


 (unaudited)











 Revenue


41,773


36,192


157,450


135,377

 Cost of revenue


25,731


22,692


99,095


84,971











 Gross profit


16,042


13,500


58,355


50,406











 Operating Expenses:










 Research and development, net


2,752


2,768


11,352


11,846


 Selling, marketing, general and administrative


8,740


7,407


32,097


26,677

 Total operating expenses


11,492


10,175


43,449


38,523











 Operating income


4,550


3,325


14,906


11,883











 Financial income, net


26


(212)


(124)


(520)

 Taxes and other expenses, net


(88)


157


454


811





















 Net income


4,612


3,380


14,576


11,592











 Attributable to non-controlling interest


(12)


(41)


113


(12)











 Net income attributable to Sapiens' shareholders


4,624


3,421


14,463


11,604





















 Basic earnings per share


0.10


0.08


0.31


0.29











 Diluted earnings per share


0.09


0.08


0.30


0.27











 Weighted average number of shares









 outstanding used to compute:



















 Basic earnings per share


47,655


42,875


47,210


40,024

 Diluted earnings per share


49,057


45,487


48,637


42,316

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)

 



  Three months ended


  Year ended



 December 31,


 December 31,



2014


2013


2014


2013

Non-GAAP revenue


41,773


36,192


157,450


135,377



















GAAP gross profit


16,042


13,500


58,355


50,406

Amortization of capitalized software


1,194


1,130


4,926


4,500

Amortization of other intangible assets


242


224


912


884

Non-GAAP gross profit


17,478


14,854


64,193


55,790



















GAAP operating income


4,550


3,325


14,906


11,883

Gross profit adjustments


1,436


1,354


5,838


5,384

Capitalization of software development


(1,556)


(1,456)


(6,094)


(5,392)

Amortization of other intangible assets


302


301


1,297


1,241

Stock-based compensation


226


234


1,067


933

Non-GAAP operating income


4,958


3,758


17,014


14,049



















GAAP net income attributable to Sapiens' shareholders


4,624


3,421


14,463


11,604

Operating income adjustments


408


433


2,108


2,166

Other


(84)


(468)


(563)


252

Non-GAAP net income attributable to Sapiens' shareholders


4,948


3,386


16,008


14,022




























Non-GAAP basic earnings per share 


0.10


0.08


0.34


0.35










Non-GAAP diluted earnings per share


0.10


0.07


0.33


0.33



















Shares used in computing US NON GAAP basic earnings per share (in thousands)

47,655


42,875


47,210


40,024

Shares used in computing US NON GAAP diluted earnings per share (in thousands)

49,057


45,487


48,637


42,316

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. Dollars in thousands

 




December 31,


December 31,




2014


2013




 (unaudited)


 (unaudited)







 ASSETS












 CURRENT ASSETS:






Cash and cash equivalents


47,400


70,313


Trade receivables, net


28,540


23,669


Other receivables and prepaid expenses


3,962


4,126


Deferred Taxes


2,319


2,420








Total current assets


82,221


100,528







 LONG-TERM ASSETS:






Marketable Securities


33,098




Property and equipment, net


4,763


5,263


Severance pay fund


10,735


11,228


Other intangible assets, net


27,060


30,014


Other long-term assets


3,248


2,957


Goodwill


67,698


72,438








 Total long-term assets


146,602


121,900







 TOTAL ASSETS


228,823


222,428







 LIABILITIES AND EQUITY











 CURRENT LIABILITIES:






Trade payables


2,952


6,517


Accrued expenses and other liabilities


25,159


20,567


Deferred revenue


9,272


9,928








Total current liabilities


37,383


37,012







 LONG-TERM LIABILITIES:






 Other long-term liabilities


3,264


2,393


 Accrued severance pay


11,980


12,615








 Total long-term liabilities


15,244


15,008







 EQUITY



176,196


170,408







 TOTAL LIABILITIES AND EQUITY


228,823


222,428

 

 

SAPIENS INTERNATIONAL CORPORATION

CONSOLIDATED STATEMENT OF CASH FLOW

U.S. Dollars in thousands

 


For the Year ended


31/12/2014

31/12/2013


(unaudited)

(unaudited)

Cash flows from operating activities:






Net income

14,576

11,592

Reconciliation of net income to net cash provided by operating activities:



Depreciation and amortization

8,717

7,887

Amortization of premium and accrued interest on marketable securities

(225)

-

Stock-based compensation related to options issued employees

1,067

933

Increase in trade receivables

(6,637)

(6,677)

Deferred tax assets

(1,020)

1,133

Decrease (Increase) in other operating assets

127

(2,317)

Increase (Decrease)  in trade payables

(3,297)

1,874

Increase in Other operating liabilities

8,469

383

Increase (Decrease)  in Deferred revenues

(223)

2,508

Increase (Decrease)  in Severance pay

7

(50)




Net cash provided by operating activities

21,561

17,266




Cash flows from investing activities:



Purchase of property and equipment

(1,468)

(4,129)

Purchase of marketable securities

(34,906)

-

Proceeds from sales of marketable securities

1,543

-

Payments for business acquisition, net of cash acquired

(2,064)

-

Increase in capitalized software development costs

(6,094)

(5,392)

Decrease (Increase)  in Restricted Cash

239

(210)

Net cash used in investing activities

(42,750)

(9,731)




Cash flows from financing activities:



Distribution of dividend

-

(5,802)

Dividend to non-controlling interests

(106)

(157)

Proceeds from employee stock options exercised

1,569

1,689

Issuance of shares upon public offering, net

-

37,791

Net cash provided by financing activities

1,463

33,521




Effect of exchange rate changes on cash and cash equivalents

(3,187)

207




Increase (Decrease) in cash and cash equivalents

(22,913)

41,263

Cash and cash equivalents at the beginning of period

70,313

29,050




Cash and cash equivalents at the end of period

47,400

70,313

Logo - http://photos.prnewswire.com/prnh/20120508/531104  

 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sapiens-reports-163-year-over-year-increase-in-annual-revenue-to-1575-million-300041102.html

SOURCE Sapiens International Corporation


[ Back To TMCnet.com's Homepage ]